How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Agriculture · Forecast 2027–2033
Clothianidin CAS 210880-92-5 Market
- By Application: Seed Treatment, Foliar Spray, Soil Treatment, Granular Application
- By Crop Type: Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Turf & Ornamentals
- By Formulation Type: Soluble Concentrate (SL), Wettable Powder (WP), Granules (GR), Emulsifiable Concentrate (EC)
- By End User: Agricultural Farms, Horticultural Farms, Turf Management, Greenhouses
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Seed Treatment leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 260 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.162 →
- 11 Company Profiles 10 players: SWOT & benchmarking p.170 →
Full report · locked preview
Everything inside the Clothianidin CAS 210880-92-5 Market report
A complete, evidence-based study - 11 chapters and 109 sections covering market size, segmentation across 4 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Application 4
Crop Type 4
Formulation Type 4
End User 4
Companies profiled
Bayer CropScience
Nufarm Limited
ADAMA Agricultural Solutions Ltd.
Shandong Rainbow Chemical Co. Ltd.
Jiangsu Yangnong Chemical Group Co. Ltd.
Hebei Veyong Pharmaceutical Co. Ltd.
Zhejiang Xinan Chemical Industrial Group Co. Ltd.
Nanjing Red Sun Co. Ltd.
Hubei Sanonda Co. Ltd.
Syngenta AG
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer CropScience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →ADAMA Agricultural Solutions Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Shandong Rainbow Chemical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Jiangsu Yangnong Chemical Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Hebei Veyong Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Zhejiang Xinan Chemical Industrial Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nanjing Red Sun Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hubei Sanonda Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Syngenta AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,852M by 2033 · 6.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Seed Treatment53.1
- Foliar Spray16.9
- Soil Treatment14.5
- Granular Application15.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$378.9M → $677.9M · 7.5%
Europe$264.1M → $416.1M · 5.8%
Asia Pacific$241.1M → $427.0M · 7.4%
Latin America$149.3M → $229.9M · 5.5%
Middle East and Africa$114.8M → $179.3M · 5.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.122026
6.132027
6.142028
6.142029
6.162030
6.172031
6.192032
6.202033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer CropScience25.5
- Nufarm Limited12.8
- ADAMA Agricultural Solutions Ltd.8.7
- Shandong Rainbow Chemical Co. Ltd.10.2
- Jiangsu Yangnong Chemical Group Co. Ltd.9.5
- Hebei Veyong Pharmaceutical Co. Ltd.5.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application19.5%
Crop Type25.5%
Formulation Type25.6%
End User29.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.1
- Europe21.6
- Asia Pacific22.1
- Latin America11.9
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer CropScience | 75 | 77 | 85 | 77 | 96 | 77 | 81 |
| Nufarm Limited | 83 | 90 | 86 | 68 | 91 | 86 | 84 |
| ADAMA Agricultural Solutions Ltd. | 69 | 68 | 71 | 75 | 66 | 68 | 70 |
| Shandong Rainbow Chemical Co. Ltd. | 58 | 82 | 68 | 67 | 75 | 77 | 71 |
| Jiangsu Yangnong Chemical Group Co. Ltd. | 64 | 58 | 60 | 59 | 57 | 60 | 60 |
| Hebei Veyong Pharmaceutical Co. Ltd. | 65 | 48 | 49 | 67 | 63 | 66 | 60 |
| Zhejiang Xinan Chemical Industrial Group Co. Ltd. | 51 | 53 | 48 | 46 | 51 | 61 | 52 |
| Nanjing Red Sun Co. Ltd. | 55 | 49 | 51 | 56 | 53 | 48 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer CropScience
- Nufarm Limited
- ADAMA Agricultural Solutions Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer CropScience | ◐ | ◐ | ◐ | ◐ | ✓ | ✓ |
| Nufarm Limited | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| ADAMA Agricultural Solutions Ltd. | − | ✓ | − | ✓ | − | ◐ |
| Shandong Rainbow Chemical Co. Ltd. | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Jiangsu Yangnong Chemical Group Co. Ltd. | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Hebei Veyong Pharmaceutical Co. Ltd. | ✓ | − | − | ◐ | ◐ | − |
| Zhejiang Xinan Chemical Industrial Group Co. Ltd. | − | − | − | − | − | − |
| Nanjing Red Sun Co. Ltd. | ◐ | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nufarm Limited84
2Bayer CropScience81
3Shandong Rainbow Chemical Co. Ltd.71
4ADAMA Agricultural Solutions Ltd.70
5Jiangsu Yangnong Chemical Group Co. Ltd.60
6Hebei Veyong Pharmaceutical Co. Ltd.60
7Zhejiang Xinan Chemical Industrial Group Co. Ltd.52
8Nanjing Red Sun Co. Ltd.52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Bayer CropScienceNufarm Limited
Challenger2
Strong scale, closing on the leaders.
ADAMA Agricultural Solutions Ltd.Shandong Rainbow Chemical Co. Ltd.
Contender2
Focused players with pockets of strength.
Jiangsu Yangnong Chemical Group Co. Ltd.Hebei Veyong Pharmaceutical Co. Ltd.
Niche2
Specialists in a single segment or region.
Zhejiang Xinan Chemical Industrial Group Co. Ltd.Nanjing Red Sun Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Clothianidin CAS 210880-92-5 Market — a $189M beachhead inside a $3.19B market.
Beachhead (SOM)$189Mobtainable near-term
Serviceable (SAM)$1.33Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Seed Treatment
Best fit — highest urgency & budget in Application.
Economic buyer80 fit
Foliar Spray
Strong fit — clear ROI and a fast path to value.
End user65 fit
Soil Treatment
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Crop Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Formulation Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve20%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Clothianidin CAS 210880-92-5 Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified23%
Evaluation13%
Closed-won5%
$14.6KCAC
$83KLTV
5.7:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Clothianidin CAS 210880-92-5 Market is a durable-growth opportunity — $1.11B by 2033, compounding at 7.7%.
TAM · 2025$614Mtoday
TAM · 2033$1.11Bforecast
CAGR7.7%2027–2033
Cumulative$7.56Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.11BTotal addressable market
SAM$403MServiceable available market
SOM$75MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.7% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.11BLarge & growingTAM by 2033 at 7.7% CAGR
$403MServiceable nowreachable with today’s model
$75MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$864MBear5.0% CAGR
$1.11BBase7.7% CAGR
$1.42BBull10.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Crop Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Clothianidin CAS 210880-92-5 Market — a $4.48B market by 2033. Plan: grow share from 8.1% to 16.7%.
Market size · 2033$4.48Btotal addressable
Market CAGR9.3%2027–2033
Target share16.7%from 8.1% today
Revenue ambition$748Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.1% | 16.7% | On track |
| Revenue | $382M | $748M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 36.5% | 41.4% | On track |
| Customer retention | 92.0% | 92.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Crop Type capability
A defensible second engine — invest in Crop Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Crop Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $103M capacity & capability investment
- Greenlight bolt-on M&A in Crop Type
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Clothianidin CAS 210880-92-5 Market conversation — a $4.52B market you can size, segment and defend in minutes.
Market size · 2033$4.52Btotal opportunity
Growth4.5%CAGR to 2033
Addressable buyers1,708+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
Bayer CropScienceNufarm LimitedADAMA Agricultural Solutions Ltd.Shandong Rainbow Chemical Co. Ltd.Jiangsu Yangnong Chemical Group Co. Ltd.Hebei Veyong Pharmaceutical Co. Ltd.Zhejiang Xinan Chemical Industrial Group Co. Ltd.Nanjing Red Sun Co. Ltd.+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Clothianidin CAS 210880-92-5 Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Clothianidin CAS 210880-92-5 Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Agriculture · scroll →Fosthiazate CAS 98886-44-3 Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportDodine CAS 2439-10-3 Market
Market size, share, segmentation and regional forecast.
$691M market · 2025 base year
View reportPhosalone CAS 2310-17-0 Market
Market size, share, segmentation and regional forecast.
$513M market · 2025 base year
View reportNaftalofos CAS 1491-41-4 Market
Market size, share, segmentation and regional forecast.
$814M market · 2025 base year
View reportRevalor-H CAS 10161-34-9 Market
Market size, share, segmentation and regional forecast.
$641M market · 2025 base year
View reportTriadimefon CAS 43121-43-3 Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportTrinexapac-ethyl CAS 95266-40-3 Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportAzocyclotin CAS 41083-11-8 Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportEthopabate CAS 59-06-3 Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportBispyribac-sodium CAS 125401-92-5 Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportCyproconazole CAS 94361-06-5 Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBenzyladenine CAS 1214-39-7 Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.